1. Home
  2. CDZI vs LCTX Comparison

CDZI vs LCTX Comparison

Compare CDZI & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CADIZ Inc.

CDZI

CADIZ Inc.

HOLD

Current Price

$4.87

Market Cap

410.6M

Sector

Utilities

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.47

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDZI
LCTX
Founded
1983
1990
Country
United States
United States
Employees
25
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.6M
407.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CDZI
LCTX
Price
$4.87
$1.47
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
467.6K
1.2M
Earning Date
05-13-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
$64.02
$55.75
Revenue Next Year
$28.16
$2.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$2.13
$0.37
52 Week High
$6.96
$2.09

Technical Indicators

Market Signals
Indicator
CDZI
LCTX
Relative Strength Index (RSI) 42.34 36.25
Support Level $4.46 $0.94
Resistance Level $5.75 $1.84
Average True Range (ATR) 0.24 0.09
MACD 0.00 -0.01
Stochastic Oscillator 36.65 14.52

Price Performance

Historical Comparison
CDZI
LCTX

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: